These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9500441

  • 1. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
    Pacilio C, Germano D, Addeo R, Altucci L, Petrizzi VB, Cancemi M, Cicatiello L, Salzano S, Lallemand F, Michalides RJ, Bresciani F, Weisz A.
    Cancer Res; 1998 Mar 01; 58(5):871-6. PubMed ID: 9500441
    [Abstract] [Full Text] [Related]

  • 2. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M, Kodet R, Strnad P.
    Cas Lek Cesk; 2002 Nov 08; 141(22):708-14. PubMed ID: 12532908
    [Abstract] [Full Text] [Related]

  • 3. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF, Blamey RW, Musgrove EA, Robertson JF, Nicholson RI, Sutherland RL.
    Oncogene; 1998 Aug 27; 17(8):1053-9. PubMed ID: 9747885
    [Abstract] [Full Text] [Related]

  • 4. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R, Lee CS, Hui R, McCaul K, Horsfall DJ, Sutherland RL.
    Clin Cancer Res; 1996 Jul 27; 2(7):1177-84. PubMed ID: 9816285
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H, Weinstein IB.
    Cancer Res; 2006 Dec 01; 66(23):11399-408. PubMed ID: 17145886
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.
    Kilker RL, Hartl MW, Rutherford TM, Planas-Silva MD.
    J Steroid Biochem Mol Biol; 2004 Sep 01; 92(1-2):63-71. PubMed ID: 15544931
    [Abstract] [Full Text] [Related]

  • 7. Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women.
    Terry MB, Gammon MD, Schoenberg JB, Brinton LA, Arber N, Hibshoosh H.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 01; 11(10 Pt 1):1100-3. PubMed ID: 12376514
    [Abstract] [Full Text] [Related]

  • 8. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
    Yang C, Trent S, Ionescu-Tiba V, Lan L, Shioda T, Sgroi D, Schmidt EV.
    Cancer Res; 2006 Dec 15; 66(24):11649-58. PubMed ID: 17178859
    [Abstract] [Full Text] [Related]

  • 9. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
    Jirström K, Stendahl M, Rydén L, Kronblad A, Bendahl PO, Stål O, Landberg G.
    Cancer Res; 2005 Sep 01; 65(17):8009-16. PubMed ID: 16140974
    [Abstract] [Full Text] [Related]

  • 10. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
    Wilcken NR, Prall OW, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 1997 Jun 01; 3(6):849-54. PubMed ID: 9815758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):161-73. PubMed ID: 15607540
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.
    Burnworth B, Popp S, Stark HJ, Steinkraus V, Bröcker EB, Hartschuh W, Birek C, Boukamp P.
    Oncogene; 2006 Jul 27; 25(32):4399-412. PubMed ID: 16547504
    [Abstract] [Full Text] [Related]

  • 18. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476
    [Abstract] [Full Text] [Related]

  • 19. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK, Sweeney KJ, Warlters A, Musgrove EA, Sutherland RL.
    Breast Cancer Res Treat; 1994 Sep 06; 31(1):95-105. PubMed ID: 7981461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.